NCT00664482View on ClinicalTrials.gov

A Single-Patient Study Using AGS 006

NACompletedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL

AGS-006

Autologous Therapy for Pancreatic Cancer

Trial Locations (1)

10021

Rockefeller University, New York

Sponsors

Lead Sponsor

Argos Therapeutics

All Listed Sponsors

lead

Argos Therapeutics

INDUSTRY

NCT00664482 - A Single-Patient Study Using AGS 006 | Biotech Hunter | Biotech Hunter